![Carfilzomib, lenalidomide and dexamethasone followed by a second ASCT is an effective strategy in first relapse multiple myeloma: a study on behalf of the Chronic malignancies working party of the EBMT | Bone Marrow Transplantation Carfilzomib, lenalidomide and dexamethasone followed by a second ASCT is an effective strategy in first relapse multiple myeloma: a study on behalf of the Chronic malignancies working party of the EBMT | Bone Marrow Transplantation](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41409-023-02048-7/MediaObjects/41409_2023_2048_Fig1_HTML.png)
Carfilzomib, lenalidomide and dexamethasone followed by a second ASCT is an effective strategy in first relapse multiple myeloma: a study on behalf of the Chronic malignancies working party of the EBMT | Bone Marrow Transplantation
Antibody-drug Conjugates in Relapsed/Refractory Multiple Myeloma: from Bench to Bedside - Springer Healthcare IME
![Myeloma Crowd Radio: Irene Ghobrial, MD & Salomon Manier, MD, PhD, Dana Farber 09/27 by HealthTree Podcast for MM | Health Myeloma Crowd Radio: Irene Ghobrial, MD & Salomon Manier, MD, PhD, Dana Farber 09/27 by HealthTree Podcast for MM | Health](https://dasg7xwmldix6.cloudfront.net/episodes/539173_RETPcwhp.jpg)
Myeloma Crowd Radio: Irene Ghobrial, MD & Salomon Manier, MD, PhD, Dana Farber 09/27 by HealthTree Podcast for MM | Health
![CHU de Lille: avancée majeure espérée dans le traitement du cancer de la moelle osseuse - La Voix du Nord CHU de Lille: avancée majeure espérée dans le traitement du cancer de la moelle osseuse - La Voix du Nord](https://lvdneng.rosselcdn.net/sites/default/files/dpistyles_v2/vdn_864w/2023/07/25/node_1356019/56416985/public/2023/07/25/B9734783257Z.1_20230725182435_000%2BGKVN6CK92.1-0.jpg?itok=iW9R3Wir1690366443)
CHU de Lille: avancée majeure espérée dans le traitement du cancer de la moelle osseuse - La Voix du Nord
![Myeloma Crowd Radio: Irene Ghobrial, MD & Salomon Manier, MD, PhD, Dana Farber 09/27 by HealthTree Podcast for MM | Health Myeloma Crowd Radio: Irene Ghobrial, MD & Salomon Manier, MD, PhD, Dana Farber 09/27 by HealthTree Podcast for MM | Health](https://www.blogtalkradio.com/api/image/resize/400x297/aHR0cHM6Ly9kYXNnN3h3bWxkaXg2LmNsb3VkZnJvbnQubmV0L2VwaXNvZGVzLzUzOTE3M180RFRiQnZmQS5qcGc/539173_4DTbBvfA.jpg?mode=Fill)
Myeloma Crowd Radio: Irene Ghobrial, MD & Salomon Manier, MD, PhD, Dana Farber 09/27 by HealthTree Podcast for MM | Health
![Next generation sequencing identifies smoldering multiple myeloma patients with a high risk of disease progression - ecancer Next generation sequencing identifies smoldering multiple myeloma patients with a high risk of disease progression - ecancer](https://cdn.ecancer.org/35340-m.jpg)
Next generation sequencing identifies smoldering multiple myeloma patients with a high risk of disease progression - ecancer
![Myeloma Crowd Radio: Irene Ghobrial, MD & Salomon Manier, MD, PhD, Dana Farber 09/27 by HealthTree Podcast for MM | Health Myeloma Crowd Radio: Irene Ghobrial, MD & Salomon Manier, MD, PhD, Dana Farber 09/27 by HealthTree Podcast for MM | Health](https://dasg7xwmldix6.cloudfront.net/episodes/539173_pt0lg8V3.jpg)